New hope for curing lung cancer: a strong predictor of resistance to immunotherapy just discovered
12 / 22 / 2023
12 / 12 / 2023
09 / 18 / 2023
06 / 26 / 2023
06 / 20 / 2023
Over the past four years, Explicyte and Bergonié Institute have been conducting joint translational research programs to identify determinants of cancer patients' responsiveness to immunotherapy. Among these efforts, Explicyte and a research team led by Pr. Italiano at Bergonié Institute identified a key biomarker predictive of the efficacy of immunotherapy in oncology.